Results for tag: "Organ Perfusion System"

The organ perfusion system market is a specialized segment within the broader context of cardiovascular devices that focuses on the maintenance and preservation of organs outside the body. These systems are designed to simulate the body's blood supply to organs, such as the heart, during surgical procedures or transplantation. Organ perfusion systems, which include heart-lung machines and other extracorporeal circulation devices, help to keep organs viable for longer periods when they are not receiving native blood flow, ensuring better outcomes for transplant patients or during lengthy cardiac surgeries. Advancements in technology within this field have led to the development of more sophisticated and precise devices that can offer better control over organ perfusion, temperature, and other critical parameters. Such devices are crucial in transplant medicine and cardiac surgery, playing a central role in patient care and success rates of procedures. The demand for these systems is propelled by an increasing prevalence of cardiovascular diseases, improvements in surgical techniques, and growing success rates of organ transplants. Some notable companies in the organ perfusion system market include Medtronic, Getinge, LivaNova, Terumo Corporation, and XENIOS AG (part of Fresenius Medical Care). These companies are recognized for their contributions to the field, producing various technologies that enable life-saving procedures and the prolongation of organ viability for transplantation. Show Less Read more